CompareNetworks publishes inaugural issue of Cell & Gene Therapy Review, delivering essential insights for a rapidly evolving industry

SAN FRANCISCO, Feb. 26, 2025 /PRNewswire/ -- CompareNetworks is proud to announce the publication of the first issue of Cell & Gene Therapy Review, marking a significant milestone in the brand's mission to provide expert insights, analysis, and strategies for the cell and gene therapy industry.

"Our goal has been to build a dedicated platform that brings together the ideas of the entire cell and gene therapy development and manufacturing community, facilitating better conversations and breaking down existing silos. The launch of our first print issue marks the beginning of what we hope will be a long and meaningful journey serving this remarkable industry," say Editor-in-Chief, Karen Langhauser.

The first issue of Cell & Gene Therapy Review is now available online and in print to professionals across the industry, offering in-depth editorial coverage on critical topics spanning research and development, clinical trials, regulatory compliance, scale-up and manufacturing, and market trends. Published quarterly, the magazine serves as a trusted resource for biopharma professionals and business leaders working to drive innovation and bring life-changing therapies to patients worldwide.

As one of the fastest-growing sectors in biopharma, cell and gene therapy continues to experience groundbreaking advancements alongside unique challenges. Cell & Gene Therapy Review is designed to keep industry stakeholders informed and ahead of the curve, providing actionable insights from leading experts in the field.

"The upcoming circulation of Cell & Gene Therapy Review's premiere print issue marks a pivotal milestone for our publication. Over the past two years, we've developed our audience within the CGT sector, strategically positioning our platform to meet the specific demands of this specialized market," says Associate Publisher, Ashley Poste.

To ensure the highest standards of editorial excellence, Cell & Gene Therapy Review is supported by a distinguished Editorial Advisory Board composed of industry leaders and experts. Their collective expertise helps shape the magazine's content, ensuring it remains a trusted and authoritative resource for professionals in the cell and gene therapy space.

About Cell & Gene Therapy Review

Cell & Gene Therapy Review is a premier quarterly publication dedicated to providing in-depth analysis, expert insights, and cutting-edge strategies for professionals in the rapidly evolving cell and gene therapy industry. Covering key topics from R&D and clinical trials to manufacturing scale-up and regulatory compliance, the magazine serves as an essential resource for scientists, engineers, and business leaders working to advance transformative therapies. To subscribe or learn more, visit www.cellgenetherapyreview.com.

About CompareNetworks, Inc.

CompareNetworks operates targeted, online B2B marketplaces for professionals worldwide. Focused on providing detailed product information for niche markets, CompareNetworks integrates online marketplaces, email newsletters, award-winning video, whitepapers, and editorial content to bring buyers and sellers together. With an extensive directory of millions of products and thousands of product videos, CompareNetworks provides the most up-to-date B2B marketplaces on the web. For more information, visit www.comparenetworks.com.

SOURCE Cell and Gene Therapy Review